Head and neck squamous cell carcinomas (HNSCC) are a group of cancers that affect cells in and around our mouth and nose. With 890,000 new cases and 450,000 deaths annually, HNSCC accounts for roughly ...
For the last 20 years, the standard-of-care adjuvant treatment for resected pathologically defined high-risk resected locally advanced squamous cell carcinoma of the head and neck (LA-SCCHN) has been ...
PRV211 represents Arm 2 of Privo's CLN-004 clinical program. Combined with Arm 1's achievement of its primary efficacy endpoint and Arm 3's dosing initiation, the program demonstrates continued ...
A Phase III clinical trial including patients at the University of Oklahoma found that proton therapy improved survival and ...
Pembrolizumab, an immune checkpoint inhibitor, has been approved by the U.S. Food and Drug Administration (FDA) for the treatment of patients with resectable locally advanced head and neck squamous ...
India Today on MSN
Thyroid cancer: Why women are three times more at risk, and why early detection save lives
As Thyroid Awareness Month highlights the rising incidence of thyroid cancer in women, experts stress that early detection ...
Hollie Thursby, 28, detailed the painful side effect she experienced when drinking a glass of wine ...
HPV status, particularly combined p16 and HPV positivity, is vital for patient selection in de-escalation strategies for ...
Smoking weed poses cancer risks beyond the lungs. Here’s what to know. Heavy marijuana use may come with a two- to eight-fold higher risk of head and neck cancer. Inhaling smoke of any kind exposes ...
HealthDay News — The rate of early termination or withdrawal in head and neck squamous cell carcinoma (HNSCC) clinical trials (CTs) has increased since 2000, with strategic decisions and poor ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results